BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38713252)

  • 1. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.
    Zhai M; Miao J; Zhang R; Liu R; Li F; Shen Y; Wang T; Xu X; Gao G; Hu J; He A; Bai J
    J Cancer Res Clin Oncol; 2024 May; 150(5):239. PubMed ID: 38713252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression.
    Yu Y; Wang XY; Sun L; Wang YL; Wan YF; Li XQ; Feng YM
    Carcinogenesis; 2014 Jun; 35(6):1416-25. PubMed ID: 24626146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESRRA promotes gastric cancer development by regulating the CDC25C/CDK1/CyclinB1 pathway via DSN1.
    Li FN; Zhang QY; Li O; Liu SL; Yang ZY; Pan LJ; Zhao C; Gong W; Shu YJ; Dong P
    Int J Biol Sci; 2021; 17(8):1909-1924. PubMed ID: 34131395
    [No Abstract]   [Full Text] [Related]  

  • 4. KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
    Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.
    Wang J; Chang L; Lai X; Li X; Wang Z; Huang Z; Huang J; Zhang G
    Cell Cycle; 2018; 17(6):671-680. PubMed ID: 29285984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin treated human glioma U87 MG cells to trigger G2/M cell cycle arrest.
    Lal N; Nemaysh V; Luthra PM
    Toxicol Appl Pharmacol; 2018 Oct; 356():76-89. PubMed ID: 30009775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
    Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
    Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G
    Zhang YX; Li XF; Yuan GQ; Hu H; Song XY; Li JY; Miao XK; Zhou TX; Yang WL; Zhang XW; Mou LY; Wang R
    J Biol Chem; 2017 May; 292(21):8933-8947. PubMed ID: 28341744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.
    Liu K; Zheng M; Zhao Q; Zhang K; Li Z; Fu F; Zhang H; Du J; Li Y; Zhang S
    J Exp Clin Cancer Res; 2020 May; 39(1):83. PubMed ID: 32393310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.
    Zhang R; Shi H; Ren F; Zhang M; Ji P; Wang W; Liu C
    J Ovarian Res; 2017 Sep; 10(1):60. PubMed ID: 28899430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell division cyclin 25C knockdown inhibits hepatocellular carcinoma development by inducing endoplasmic reticulum stress.
    Li YF; Zheng FY; Miao XY; Liu HL; Zhang YY; Chao NX; Mo FR
    World J Gastroenterol; 2024 May; 30(19):2564-2574. PubMed ID: 38817663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CDC2/Cyclin B1 in response to selenium-induced oxidative stress during spermatogenesis: potential role of Cdc25c and p21.
    Kaushal N; Bansal MP
    Mol Cell Biochem; 2007 Apr; 298(1-2):139-50. PubMed ID: 17160696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1.
    Herman-Antosiewicz A; Kim YA; Kim SH; Xiao D; Singh SV
    Pharm Res; 2010 Jun; 27(6):1072-9. PubMed ID: 20143254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.
    Liu Q; Tao B; Liu G; Chen G; Zhu Q; Yu Y; Yu Y; Xiong H
    J Biol Chem; 2016 Feb; 291(9):4779-92. PubMed ID: 26724804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma.
    Liu Y; Li RH; Ren G; Jiang J
    Biomed Res Int; 2020; 2020():6387545. PubMed ID: 32090103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.
    Xiao D; Johnson CS; Trump DL; Singh SV
    Mol Cancer Ther; 2004 May; 3(5):567-75. PubMed ID: 15141014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of di-n-butyl-(2,6-difluorobenzohydroxamato)tin(IV) against human gastric carcinoma SGC-7901 cells via G2/M cell cycle arrest and cell apoptosis.
    Yunlan L; Juan Z; Qingshan L
    PLoS One; 2014; 9(3):e90793. PubMed ID: 24643073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Fluoride Arrests Renal G2/M Phase Cell-Cycle Progression by Activating ATM-Chk2-P53/Cdc25C Signaling Pathway in Mice.
    Luo Q; Guo H; Kuang P; Cui H; Deng H; Liu H; Lu Y; Wei Q; Chen L; Fang J; Zuo Z; Deng J; Li Y; Wang X; Zhao L
    Cell Physiol Biochem; 2018; 51(5):2421-2433. PubMed ID: 30537743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Colon Cancer.
    Li B; Zhu FC; Yu SX; Liu SJ; Li BY
    Cancer Biother Radiopharm; 2020 Feb; 35(1):50-57. PubMed ID: 31657617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.